How is nicotine gum metabolized?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nicotine Gum Metabolism

Nicotine from gum is absorbed through the oral mucosa and metabolized primarily in the liver by the cytochrome P450 enzyme CYP2A6, which converts approximately 70-80% of nicotine to cotinine, the major metabolite that is then further metabolized and excreted in urine. 1, 2

Primary Metabolic Pathway

  • Nicotine undergoes first-pass hepatic metabolism, with almost 90% of absorbed nicotine metabolized in the liver 1
  • CYP2A6 is the dominant enzyme responsible for nicotine C-oxidation to cotinine, accounting for the majority of nicotine metabolism 2, 3
  • Cotinine formation shows a 30-fold variation among individuals due to variable CYP2A6 expression 2

Absorption Characteristics Specific to Gum

  • Absorption from nicotine gum occurs through the oral mucosa rather than the gastrointestinal tract, which is critical because oral bioavailability would be less than 20% due to extensive first-pass metabolism 4
  • Absorption through the oral mucosa is highly pH-dependent, with alkaline environments increasing the rate of nicotine permeation through biological membranes 1, 4
  • This pH-dependency explains why acidic beverages should be avoided 15 minutes before and during gum use, as they reduce nicotine absorption 4

Additional Metabolic Enzymes

Beyond CYP2A6, several other enzymes contribute to nicotine metabolism 1, 5:

  • UDP-glucuronosyltransferases (UGT) participate in conjugation reactions
  • Flavin-containing monooxygenase 3 (FMO3) provides an alternative oxidative pathway
  • Cytosolic aldehyde oxidase converts nicotine iminium ion to cotinine
  • Amine N-methyltransferase catalyzes minor metabolic pathways

Major Metabolites

  • Cotinine is the primary metabolite, serving as the most widely used biomarker of nicotine intake 6, 5
  • Trans-3'-hydroxycotinine is formed from cotinine and represents the compound excreted in the largest amount in urine 1
  • Six major metabolites of nicotine have been identified in total 1

Sites of Metabolism

While the liver is the primary site 1:

  • Nicotine may also be metabolized in the kidneys, lungs, brain, and respiratory epithelium membranes 1
  • Non-renal blood clearance averages 1.2 L/min, indicating nicotine elimination is dependent on hepatic blood flow 4

Factors Affecting Metabolism Rate

Nicotine metabolism varies substantially based on 5:

  • Genetic polymorphisms in CYP2A6 (explaining the 30-fold variation in metabolism rates) 2
  • Sex differences (women metabolize nicotine faster, especially when using estrogen-containing preparations)
  • Diet and meals
  • Age
  • Pregnancy
  • Kidney disease
  • Concomitant medications that affect hepatic blood flow
  • Racial/ethnic differences (likely influenced by both genetic and environmental factors)

Excretion

  • Nicotine is excreted unchanged in urine in a pH-dependent fashion: with urinary pH less than 5, an average 23% is excreted unchanged; when pH is maintained above 7.0, unchanged nicotine excretion drops to 2% 4
  • The majority of nicotine is excreted as metabolites, primarily trans-3'-hydroxycotinine 1

Clinical Relevance

  • Total plasma clearance ranges from 0.92 to 2.43 L/min 4
  • Plasma protein binding is negligible (4.9-20%), allowing extensive tissue distribution with a volume of distribution of 1.0-3.0 L/kg 4
  • CYP2D6 plays no significant role in nicotine metabolism, as demonstrated by lack of inhibition with quinidine and failure of CYP2D6 expression systems to metabolize nicotine 2

References

Research

A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.

The Journal of pharmacology and experimental therapeutics, 1997

Research

Role of human cytochrome P4502A6 in C-oxidation of nicotine.

Drug metabolism and disposition: the biological fate of chemicals, 1996

Research

Clinical pharmacokinetics of nicotine.

Clinical pharmacokinetics, 1987

Research

Nicotine chemistry, metabolism, kinetics and biomarkers.

Handbook of experimental pharmacology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.